EUVIMEDEUVIMED entdecken
Crossref

Alzheimer’s Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers

Chiara Milano, Domeniko Hoxhaj, Marta Del Chicca, Alessia Pascazio, Davide Paoli, Luca Tommasini, Andrea Vergallo, Chiara Pizzanelli, Gloria Tognoni, Angelo Nuti, Roberto Ceravolo, Gabriele Siciliano und 3 weitere

Journal of Alzheimer's Disease · 18.07.2023 · 94 (2) · 611-625

DOI: 10.3233/jad-230170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 18.07.2023. Verfasst von Chiara Milano und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Cognitive Dysfunction, Neurosyphilis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 90 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neurosyphilis-associated cognitive and behavioral impairment— historically coined as “general paralysis of the insane”— share clinical and neuroradiological features with the neurodegenerative disease spectrum, in particular Alzheimer’s disease (AD). Anatomopathological similarities have been extensively documented, i.e., neuronal loss, fibrillary alterations, and local amyloid-β deposition. Consequently, accurate classification and timely differential diagnosis may be challenging.

Objective

To describe clinical, bio-humoral, brain MRI, FDG-PET, and amyloid-PET features in cases of neurosyphilis with an AD-like phenotypical presentation, as well as clinical outcome in terms of response to antibiotic therapy.

Methods

We selected the studies comparing patients with AD and with neurosyphilis associated cognitive impairment, to investigate candidate biomarkers classifying the two neurological diseases.

Results

The neuropsychological phenotype of general paralysis, characterized by episodic memory impairment and executive disfunction, substantially mimics clinical AD features. Neuroimaging often shows diffuse or medial temporal cortical atrophy, thus contributing to a high rate of misdiagnosis. Cerebrospinal fluid (CSF)-based analysis may provide supportive diagnostic value, since increased proteins or cells are often found in neurosyphilis, while published data on pathophysiological AD candidate biomarkers are controversial. Finally, psychometric testing using cross-domain cognitive tests, may highlight a wider range of compromised functions in neurosyphilis, involving language, attention, executive function, and spatial ability, which are atypical for AD.

Conclusion

Neurosyphilis should be considered a potential etiological differential diagnosis of cognitive impairment whenever imaging, neuropsychological or CSF features are atypical for AD, in order to promptly start antibiotic therapy and delay or halt cognitive decline and disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesCognitive DysfunctionNeurosyphilisHumansAmyloid beta-PeptidesBiomarkersPositron-Emission TomographyNeuropsychological TestsPhenotypeAnti-Bacterial Agentstau Proteins

Stichwörter der Autor:innen

Alzheimer’s diseasebiomarkersgeneral paralysisneurosyphilistreatable dementia

Substanzen

Amyloid beta-PeptidesBiomarkersAnti-Bacterial Agentstau Proteins

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Sorbonne University, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Division of Neurology, Versilia Hospital, Lido di Camaiore, Italy.

Zitieren

APA

Milano, C., Hoxhaj, D., Del Chicca, M., Pascazio, A., Paoli, D., Tommasini, L., Vergallo, A., Pizzanelli, C., Tognoni, G., Nuti, A., Ceravolo, R., Siciliano, G., Hampel, H., Baldacci, F., & Neurodegeneration Precision Medicine Initiative (NPMI) (2023). Alzheimer’s Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers. Journal of Alzheimer's Disease, 94(2), 611-625. https://doi.org/10.3233/jad-230170

Vancouver

Milano C, Hoxhaj D, Del Chicca M, Pascazio A, Paoli D, Tommasini L, et al. Alzheimer’s Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers. Journal of Alzheimer's Disease. 2023;94(2):611-625. doi:10.3233/jad-230170

BibTeX
@article{Milano2023,
  author = {Milano, Chiara and Hoxhaj, Domeniko and Del Chicca, Marta and Pascazio, Alessia and Paoli, Davide and Tommasini, Luca and Vergallo, Andrea and Pizzanelli, Chiara and Tognoni, Gloria and Nuti, Angelo and Ceravolo, Roberto and Siciliano, Gabriele and Hampel, Harald and Baldacci, Filippo and Neurodegeneration Precision Medicine Initiative (NPMI), Neurodegeneration Precision Medicine Initiative (NPMI)},
  title = {Alzheimer’s Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  volume = {94},
  number = {2},
  pages = {611--625},
  doi = {10.3233/jad-230170}
}
Kostenlos starten →